CFTR in K562 human leukemic cells

被引:9
|
作者
Assef, YA
Damiano, AE
Zotta, E
Ibarra, C
Kotsias, BA
机构
[1] Univ Buenos Aires, Inst Invest Med Alfredo Lanari, Fac Med, RA-1427 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Dept Fisiol, Fac Med, RA-1427 Buenos Aires, DF, Argentina
来源
关键词
CFTR; K562; cells; leukemia cells; ion channels; glibenclamide; DIDS; PCR; immunohistochemistry;
D O I
10.1152/ajpcell.00320.2002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study, the expression and functional characterization of CFTR ( cystic fibrosis transmembrane regulator) was determined in K562 chronic human leukemia cells. Expression of the CFTR gene product was determined by RT-PCR and confirmed by immunohistochemistry and Western blot analysis. Functional characterization of CFTR Cl- channel activity was conducted with patch-clamp techniques. Forskolin, an adenylyl cyclase activator, induced an anion-selective channel with a linear current-voltage relationship and a single-channel conductance of 11 pS. This cAMP-activated channel had a P-gluconate/P-Cl or P-F/P-Cl perm-selectivity ratio of 0.35 and 0.30, respectively, and was inhibited by the CFTR blocker glibenclamide and the anti-CFTR antibody MAb 13-1, when added to the cytoplasmatic side of the patch. Glibenclamide decreased the open probability increasing the frequency of open-to-closed transitions. Addition of 200 muM DIDS caused an irreversible block of the channels when added to the cytosolic side of inside-out patches. These and other observations indicate a widespread distribution of CFTR gene expression and suggest that this channel protein may function in most human cells to help maintain cellular homeostasis.
引用
收藏
页码:C480 / C488
页数:9
相关论文
共 50 条
  • [1] Ionic currents in multidrug resistant K562 human leukemic cells
    Assef, YA
    Cavarra, SM
    Damiano, AE
    Ibarra, C
    Kotsias, BA
    [J]. LEUKEMIA RESEARCH, 2005, 29 (09) : 1039 - 1047
  • [2] Grandisin induces apoptosis in leukemic K562 cells
    Cortez, Alane Pereira
    Paulino Menezes, Elizabeth Gomes
    Benfica, Polyana Lopes
    dos Santos, Alexandre Pereira
    Cleres, Larissa Moreira
    Ribeiro, Higor de Oliveira
    Lima, Eliana Martins
    Kato, Massuo Jorge
    Valadares, Marize Campos
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 53 (01)
  • [3] BIOCHEMICAL CONSEQUENCES OF RESISTANCE TO TIAZOFURIN IN HUMAN MYELOGENOUS LEUKEMIC K562 CELLS
    JAYARAM, HN
    ZHEN, WN
    GHAREHBAGHI, K
    [J]. CANCER RESEARCH, 1993, 53 (10) : 2344 - 2348
  • [4] Imatinib resistance in multidrug-resistant K562 human leukemic cells
    Assef, Yanina
    Rubio, Fernanda
    Colo, Georgina
    del Monaco, Silvana
    Costas, Monica A.
    Kotsias, Basilio A.
    [J]. LEUKEMIA RESEARCH, 2009, 33 (05) : 710 - 716
  • [5] Characterization of nucleobase-specific transport in human leukemic K562 cells
    Maeda, T
    Kato, R
    Toyama, K
    Tamai, I
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2004, 124 : 225 - 228
  • [6] STUDIES OF THE DIFFERENTIATION PROPERTIES OF CAMPTOTHECIN IN THE HUMAN LEUKEMIC-CELLS K562
    MCSHEEHY, PMJ
    GERVASONI, M
    LAMPASONA, V
    ERBA, E
    DINCALCI, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (11) : 1406 - 1411
  • [7] HEMOGLOBIN INDUCTION IN K562 HUMAN-LEUKEMIC CELLS WITH HEMIN, PROTOPORPHYRIN, AND THYMIDINE
    HOLLIFIELD, KL
    LUMADUE, JA
    DIAMOND, AP
    MURNANE, MJ
    MAHONEY, MJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1981, 33 (06) : A146 - A146
  • [8] K562 HUMAN-LEUKEMIC CELLS SYNTHESIZE EMBRYONIC HEMOGLOBIN IN RESPONSE TO HEMIN
    RUTHERFORD, TR
    CLEGG, JB
    WEATHERALL, DJ
    [J]. NATURE, 1979, 280 (5718) : 164 - 165
  • [9] MORPHOLOGICAL MODIFICATIONS LINKED TO RESISTANCE TO ADRIAMYCIN IN K562 HUMAN-LEUKEMIC CELLS
    DUFER, J
    AKELI, MG
    JEANNESSON, P
    BENOIST, H
    DESPLACES, A
    JARDILLIER, JC
    [J]. BULLETIN DU CANCER, 1987, 74 (06) : 669 - 670
  • [10] Proteasomal degradation of oxidatively damaged endogenous histones in K562 human leukemic cells
    Ullrich, O
    Grune, T
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (07) : 887 - 893